Summary

The global market for Erectile Dysfunction Drugs was estimated to be worth US$ 6340 million in 2024 and is forecast to a readjusted size of US$ 10050 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share. The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Market trends and future development
Market demand continues to grow: With the increase in ED prevalence and the younger patient population, the market demand for ED drugs will continue to grow.
New products and new dosage forms continue to emerge: In order to meet the diverse needs of patients, new pharmaceutical companies continue to develop new products and new dosage forms, such as orodisintegrating tablets and long-acting preparations.
Policy incentives and market access: The government's attention to men's health issues and the improvement of drug supervision and market access mechanisms will provide more development opportunities for the ED drug market.
New retail channels and digital marketing: With the rise of new retail channels and the popularization of digital marketing, the ED drug market will pay more attention to user experience and personalized services.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Erectile Dysfunction Drugs by region & country, by Type, and by Application.
The Erectile Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Pill) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Drugs.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Erectile Dysfunction Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Erectile Dysfunction Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Erectile Dysfunction Drugs Product Introduction
1.2 Global Erectile Dysfunction Drugs Market Size Forecast
1.2.1 Global Erectile Dysfunction Drugs Sales Value (2020-2031)
1.2.2 Global Erectile Dysfunction Drugs Sales Volume (2020-2031)
1.2.3 Global Erectile Dysfunction Drugs Sales Price (2020-2031)
1.3 Erectile Dysfunction Drugs Market Trends & Drivers
1.3.1 Erectile Dysfunction Drugs Industry Trends
1.3.2 Erectile Dysfunction Drugs Market Drivers & Opportunity
1.3.3 Erectile Dysfunction Drugs Market Challenges
1.3.4 Erectile Dysfunction Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Erectile Dysfunction Drugs Players Revenue Ranking (2024)
2.2 Global Erectile Dysfunction Drugs Revenue by Company (2020-2025)
2.3 Global Erectile Dysfunction Drugs Players Sales Volume Ranking (2024)
2.4 Global Erectile Dysfunction Drugs Sales Volume by Company Players (2020-2025)
2.5 Global Erectile Dysfunction Drugs Average Price by Company (2020-2025)
2.6 Key Manufacturers Erectile Dysfunction Drugs Manufacturing Base and Headquarters
2.7 Key Manufacturers Erectile Dysfunction Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Erectile Dysfunction Drugs
2.9 Erectile Dysfunction Drugs Market Competitive Analysis
2.9.1 Erectile Dysfunction Drugs Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Erectile Dysfunction Drugs Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Drugs as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sildenafil
3.1.2 Tadalafil
3.1.3 Others
3.2 Global Erectile Dysfunction Drugs Sales Value by Type
3.2.1 Global Erectile Dysfunction Drugs Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Erectile Dysfunction Drugs Sales Value, by Type (2020-2031)
3.2.3 Global Erectile Dysfunction Drugs Sales Value, by Type (%) (2020-2031)
3.3 Global Erectile Dysfunction Drugs Sales Volume by Type
3.3.1 Global Erectile Dysfunction Drugs Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Erectile Dysfunction Drugs Sales Volume, by Type (2020-2031)
3.3.3 Global Erectile Dysfunction Drugs Sales Volume, by Type (%) (2020-2031)
3.4 Global Erectile Dysfunction Drugs Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Private Clinics
4.1.3 Retail Pharmacies
4.1.4 E-Commerce (B2B)
4.1.5 E-Commerce (B2C)
4.2 Global Erectile Dysfunction Drugs Sales Value by Application
4.2.1 Global Erectile Dysfunction Drugs Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Erectile Dysfunction Drugs Sales Value, by Application (2020-2031)
4.2.3 Global Erectile Dysfunction Drugs Sales Value, by Application (%) (2020-2031)
4.3 Global Erectile Dysfunction Drugs Sales Volume by Application
4.3.1 Global Erectile Dysfunction Drugs Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Erectile Dysfunction Drugs Sales Volume, by Application (2020-2031)
4.3.3 Global Erectile Dysfunction Drugs Sales Volume, by Application (%) (2020-2031)
4.4 Global Erectile Dysfunction Drugs Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Erectile Dysfunction Drugs Sales Value by Region
5.1.1 Global Erectile Dysfunction Drugs Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Erectile Dysfunction Drugs Sales Value by Region (2020-2025)
5.1.3 Global Erectile Dysfunction Drugs Sales Value by Region (2026-2031)
5.1.4 Global Erectile Dysfunction Drugs Sales Value by Region (%), (2020-2031)
5.2 Global Erectile Dysfunction Drugs Sales Volume by Region
5.2.1 Global Erectile Dysfunction Drugs Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Erectile Dysfunction Drugs Sales Volume by Region (2020-2025)
5.2.3 Global Erectile Dysfunction Drugs Sales Volume by Region (2026-2031)
5.2.4 Global Erectile Dysfunction Drugs Sales Volume by Region (%), (2020-2031)
5.3 Global Erectile Dysfunction Drugs Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Erectile Dysfunction Drugs Sales Value, 2020-2031
5.4.2 North America Erectile Dysfunction Drugs Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Erectile Dysfunction Drugs Sales Value, 2020-2031
5.5.2 Europe Erectile Dysfunction Drugs Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Erectile Dysfunction Drugs Sales Value, 2020-2031
5.6.2 Asia Pacific Erectile Dysfunction Drugs Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Erectile Dysfunction Drugs Sales Value, 2020-2031
5.7.2 South America Erectile Dysfunction Drugs Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Erectile Dysfunction Drugs Sales Value, 2020-2031
5.8.2 Middle East & Africa Erectile Dysfunction Drugs Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Erectile Dysfunction Drugs Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Erectile Dysfunction Drugs Sales Value and Sales Volume
6.2.1 Key Countries/Regions Erectile Dysfunction Drugs Sales Value, 2020-2031
6.2.2 Key Countries/Regions Erectile Dysfunction Drugs Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Erectile Dysfunction Drugs Sales Value, 2020-2031
6.3.2 United States Erectile Dysfunction Drugs Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Erectile Dysfunction Drugs Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Erectile Dysfunction Drugs Sales Value, 2020-2031
6.4.2 Europe Erectile Dysfunction Drugs Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Erectile Dysfunction Drugs Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Erectile Dysfunction Drugs Sales Value, 2020-2031
6.5.2 China Erectile Dysfunction Drugs Sales Value by Type (%), 2024 VS 2031
6.5.3 China Erectile Dysfunction Drugs Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Erectile Dysfunction Drugs Sales Value, 2020-2031
6.6.2 Japan Erectile Dysfunction Drugs Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Erectile Dysfunction Drugs Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Erectile Dysfunction Drugs Sales Value, 2020-2031
6.7.2 South Korea Erectile Dysfunction Drugs Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Erectile Dysfunction Drugs Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Erectile Dysfunction Drugs Sales Value, 2020-2031
6.8.2 Southeast Asia Erectile Dysfunction Drugs Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Erectile Dysfunction Drugs Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Erectile Dysfunction Drugs Sales Value, 2020-2031
6.9.2 India Erectile Dysfunction Drugs Sales Value by Type (%), 2024 VS 2031
6.9.3 India Erectile Dysfunction Drugs Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Information
7.1.2 Eli Lilly Introduction and Business Overview
7.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Eli Lilly Erectile Dysfunction Drugs Product Offerings
7.1.5 Eli Lilly Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pfizer Erectile Dysfunction Drugs Product Offerings
7.2.5 Pfizer Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Introduction and Business Overview
7.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bayer Erectile Dysfunction Drugs Product Offerings
7.3.5 Bayer Recent Development
7.4 BaiYunShan General Factory
7.4.1 BaiYunShan General Factory Company Information
7.4.2 BaiYunShan General Factory Introduction and Business Overview
7.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Offerings
7.4.5 BaiYunShan General Factory Recent Development
7.5 S.K. Chemicals
7.5.1 S.K. Chemicals Company Information
7.5.2 S.K. Chemicals Introduction and Business Overview
7.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Offerings
7.5.5 S.K. Chemicals Recent Development
7.6 Teva Pharma
7.6.1 Teva Pharma Company Information
7.6.2 Teva Pharma Introduction and Business Overview
7.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Teva Pharma Erectile Dysfunction Drugs Product Offerings
7.6.5 Teva Pharma Recent Development
7.7 Dong-A ST
7.7.1 Dong-A ST Company Information
7.7.2 Dong-A ST Introduction and Business Overview
7.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Dong-A ST Erectile Dysfunction Drugs Product Offerings
7.7.5 Dong-A ST Recent Development
7.8 Petros Pharmaceuticals
7.8.1 Petros Pharmaceuticals Company Information
7.8.2 Petros Pharmaceuticals Introduction and Business Overview
7.8.3 Petros Pharmaceuticals Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Petros Pharmaceuticals Erectile Dysfunction Drugs Product Offerings
7.8.5 Petros Pharmaceuticals Recent Development
7.9 Seoul Pharma
7.9.1 Seoul Pharma Company Information
7.9.2 Seoul Pharma Introduction and Business Overview
7.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Offerings
7.9.5 Seoul Pharma Recent Development
7.10 CSBIO.
7.10.1 CSBIO. Company Information
7.10.2 CSBIO. Introduction and Business Overview
7.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 CSBIO. Erectile Dysfunction Drugs Product Offerings
7.10.5 CSBIO. Recent Development
8 Industry Chain Analysis
8.1 Erectile Dysfunction Drugs Industrial Chain
8.2 Erectile Dysfunction Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Erectile Dysfunction Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Erectile Dysfunction Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer